Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 11:5:14-6.
doi: 10.2174/1874364101105010014.

Corneal cross-linking and safety issues

Eberhard Spoerl  1 , Anne Hoyer, Lutz E Pillunat, Frederik Raiskup
Affiliations

Corneal cross-linking and safety issues

Eberhard Spoerl et al. Open Ophthalmol J. .

Abstract

Purpose: To compile the safety aspects of the corneal collagen cross-linking (CXL) by means of the riboflavin/UVA (370 nm) approach.

Materials and methodology: Analysis of the current treatment protocol with respect to safety during CXL.

Results: The currently used UVA dose density of 5.4 J/cm(2) and the corresponding irradiance of 3 mW/cm(2) are below the known damage thresholds of UVA for the corneal endothelium, lens, and retina. Regarding the photochemical damages due to the free radicals the damage threshold for endothelial cells is 0.35 mW/cm(2). In a 400μm thick corneal stroma saturated with riboflavin, the irradiance at the endothelial level is about 0.18 mW/cm(2), which is a factor of 2 smaller than the damage threshold.

Conclusion: As long as the corneal stroma treated has a minimal thickness of 400 microns (as recommended), neither corneal endothelium nor deeper structures such as lens and retina will suffer any damages. The light source should provide a homogenous irradiance avoiding hot spots.

Keywords: Keratoconus; biomechanics; cornea; cross-linking.; ultraviolet light.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Safety aspects of corneal cross-linking with riboflavin and UVA.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97–103. - PubMed
    1. Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg. 1999;15:711–3. - PubMed
    1. Spörl E, Schreiber J, Hellmund K, Seiler T, Knuschke P. Studies on the stabilization of the cornea in rabbits. Ophthalmologe. 2000;97:203–6. - PubMed
    1. Wollensak G, Spörl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res. 2003;35:324–8. - PubMed
    1. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg. 2003;29:1786–90. - PubMed